Endless Frontier Labs
Bristol, October 10th 2023: EnsiliTech, a leading innovator in the biotechnology industry, is proud to announce its acceptance into the esteemed Endless Frontier Labs (EFL) programme.
The EFL programme, hosted by New York University’s Stern School of Business, is a nine-month initiative focused on maximizing the potential of massively-scalable, science and deep technology startups. This programme provides startup founders with invaluable advice from serial entrepreneurs, investors, and technical mentors to accomplish individualized business goals at eight-week intervals.
“We are thrilled to be part of this prestigious programme,” said Dr Asel Sartbaeva, CEO at EnsiliTech. “We believe that our participation in the EFL will significantly accelerate our growth and innovation. Allowing us to continue to deliver game changing technological development.”
The programme is highly competitive, with nearly 1,400 different groups applied to participate in the latest EFL programme, with only 78 being accepted. EnsiliTech will join a cohort of startups that are developing groundbreaking technologies and solutions. Past participants have made significant strides in areas such as space technology, Internet-of-Things, healthcare, and more.
“We look forward to leveraging the resources and mentorship provided by the EFL programme to further our mission of creating a world free of cold chain dependence, and improving the access of vital life changing medications across the world,” added Asel.
EnsiliTech is a Bristol-based startup, which spun out from the University of Bath in July 2022. In January 2023, EnsiliTech had finalised a first, oversubscribed, pre-seed investment round of £1.2M. This consisted of an Innovate UK grant and private investment from Science Angels Syndicate, Fink Family Office, QantX, and angels.
If you’d like to find out more about our technology, or explore partnership opportunities, contact hello@ensilitech.com
